State Street’s Medline Inc MDLN Stock Holding History

State Street’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$215M	Buy	4,822,383 +3,823,186	+383%	+$169M	0.01%	898
2025 Q4	$42M	Buy	+999,197	New	+$42.2M	﹤0.01%	1836

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

State Street's MDLN Position: Q1 2026 in Review

State Street increased its Medline Inc (MDLN) stake by 383% in Q1 2026, buying an estimated $169M and bringing the position to 4,822,383 shares worth $215M. The position accounts for 0.01% of the portfolio, ranked #898.

State Street first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

State Street held 4,822,383 shares of Medline Inc worth $215M as of Q1 2026.
State Street bought 3,823,186 Medline Inc shares in Q1 2026, an estimated $169M.
Medline Inc made up 0.01% of State Street's portfolio in Q1 2026, its #898 holding.
State Street first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.